
Microbia: Industrial biotech firm specializing in developing, producing, and commercializing specialty biomaterials.
Microbia is an industrial biotechnology company focused on the development, production, and commercialization of specialty ingredients and biomaterials through fermentation technology. Its product portfolio includes carotenoids, specialty ingredients, biopolymers, and other biomaterials. The company targets markets that benefit from renewable and sustainable ingredients. Microbia has formed a strategic alliance with Tate & Lyle Investments, Ltd. to advance the development and commercialization of fermentation-derived renewable ingredients.
Microbia has made significant strides in the biotechnology sector by leveraging its expertise in fermentation technology to produce high-value specialty ingredients and biomaterials. The partnership with Tate & Lyle Investments has bolstered its capabilities in bringing innovative, sustainable products to market. This collaboration underscores Microbia's impact on the industry by promoting environmentally friendly alternatives and advancing the use of renewable resources in various applications.

Allied Microbiota

Microbiome Therapeutics

Conagen

Biomiic

Amicrobe
amicrobe.com

Microbiotix
microbiotix.com

Bolt Projects Holdings
boltthreads.com

Native Microbials

Genomatica
genomatica.com

microTERRA
microterra.com.mx

Microbion
microbioncorp.com

Microvi Biotech

Shoreline Biome
intusbio.com

Industrial Microbes
imicrobes.com

MicroBio Engineering
Companies similar to Microbia include Allied Microbiota, Microbiome Therapeutics, Conagen and Biomiic.
Microbia was founded in 1998.
Microbia's headquarters is located in Lexington, MA, US.
Microbia's most recent funding round was for $50M (USD) in March 2007.
As of Mar 1, 2007, Microbia has raised a total of $213.3M (USD).